. They discovered the concentration of HBsAg secreted during the mobile society and mouse serum was reduced by CRISPR/Cas9 cure. They concluded that a CRISPR/Cas9 method inhibited HBV replication and expression in vitro and in vivo Also, this technique could inactivate the mutation of residual viral DNA. They concluded that https://davidz863nsw6.bcbloggers.com/profile